Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Moynihan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Psychiatric Quarterly|January 1, 1992
Adult lifetime prevalence of firesetting behaviors in a state hospital populationJ L Geller, W H Fisher, K Moynihan
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2000
Participation in research: the economic advantages in a haemophilia research populationJ Wasserman, M Ullman, M Cantini, et al.
Journal of the American Board of Family Medicine : JABFM|July 11, 2018
Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug PromotionCaitlin K Moynihan, Panne A Burke, Sarah A Evans, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|February 15, 2001
High-throughput SNP genotyping with the Masscode systemM Kokoris, K Dix, K Moynihan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Enhancement of melphalan activity by inhibition of DNA polymerase-alpha and DNA polymerase-betaK Moynihan, G B Elion, F Ali-Osman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
L-amino acid oxidase (LOX) modulation of melphalan activity against intracranial gliomaK Moynihan, G B Elion, C Pegram, et al.
Irish Journal of Medical Science|March 5, 2009
Awareness of diabetes complications in an Irish populationE P O'Sullivan, A Bhargava, M O'Callaghan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Psychiatric Quarterly|January 1, 1992
Adult lifetime prevalence of firesetting behaviors in a state hospital populationJ L Geller, W H Fisher, K Moynihan
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2000
Participation in research: the economic advantages in a haemophilia research populationJ Wasserman, M Ullman, M Cantini, et al.
Journal of the American Board of Family Medicine : JABFM|July 11, 2018
Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug PromotionCaitlin K Moynihan, Panne A Burke, Sarah A Evans, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|February 15, 2001
High-throughput SNP genotyping with the Masscode systemM Kokoris, K Dix, K Moynihan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Enhancement of melphalan activity by inhibition of DNA polymerase-alpha and DNA polymerase-betaK Moynihan, G B Elion, F Ali-Osman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
L-amino acid oxidase (LOX) modulation of melphalan activity against intracranial gliomaK Moynihan, G B Elion, C Pegram, et al.
Irish Journal of Medical Science|March 5, 2009
Awareness of diabetes complications in an Irish populationE P O'Sullivan, A Bhargava, M O'Callaghan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.
Pageof 1